Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Huzhang-Xiangbaji compounds enhance the repair of meniscal cartilage by inhibiting ferroptosis and inflammatory microenvironment. | Phytomedicine | 2026 | 41795292 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Promoting intervertebral disc fusion using BMP2, L51P, and the EP4 agonist KMN-159: synergistic osteogenesis in human annulus fibrosus cells. | Eur Spine J | 2026 | 41774213 | PubTator, text mining | PubMed |
| Artificial Intelligence in Lung Cancer: A Narrative Review of Recent Advances in Diagnosis, Biomarker Discovery, and Drug Development. | Pharmaceutics | 2026 | 41754942 | PubTator, text mining | PubMed |
| Immuno-Instructive 3D Tendon Biomimetic Scaffolds Functionalized with Amniotic Epithelial Stem Cell Secretome for Controlled Inflammation and Targeted Macrophage Polarization. | Int J Mol Sci | 2026 | 41752165 | PubTator, text mining | PubMed |
| Stage-Dependent Role of Eicosanoids in Colorectal Cancer. | Int J Mol Sci | 2026 | 41751779 | PubTator, text mining | PubMed |
| SPP1+ Macrophages and the Orchestration of Spatially Organized Immunosuppression in Cancer. | Biomedicines | 2026 | 41751193 | PubTator, text mining | PubMed |
| Prostaglandin E1 in ischemic retinal diseases: mechanisms, evidence, and clinical perspectives. | Front Med (Lausanne) | 2026 | 41737389 | PubTator, text mining | PubMed |
| Prostaglandin E2-EP4 Signaling at the Gut-Immune-Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance. | Compr Physiol | 2026 | 41725055 | PubTator, text mining | PubMed |
| Fluid Overload-Associated Large B-Cell Lymphoma Presenting as Isolated Pleural Effusion. | Hematol Rep | 2026 | 41718415 | PubTator, text mining | PubMed |
| Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. | Front Oncol | 2026 | 41717407 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma. | Crit Rev Immunol | 2026 | 41711658 | PubTator, text mining | PubMed |
| Lipid Metabolism-Driven CNS Repair via Targeted EV Delivery of PAF to Neurons. | J Extracell Vesicles | 2026 | 41711649 | PubTator, text mining | PubMed |
| Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer. | Front Immunol | 2026 | 41710887 | PubTator, text mining | PubMed |
| Mechanistic basis for the antifibrotic actions of cAMP-based therapies. | Eur Respir Rev | 2026 | 41708123 | PubTator, text mining | PubMed |
| Enteric nervous system and inflammatory bowel disease. | Gastroenterol Rep (Oxf) | 2026 | 41696441 | PubTator, text mining | PubMed |
| Lipid metabolism in homeostasis and disease. | Signal Transduct Target Ther | 2026 | 41692800 | PubTator, text mining | PubMed |
| Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours. | Nat Biomed Eng | 2026 | 41673138 | PubTator, text mining | PubMed |
| Nuclear PD-L1 regulates YAP-driven transcription via the PGE2-EP4-YAP-importin α3 axis in solid tumors. | Cell Rep | 2026 | 41671087 | PubTator, text mining | PubMed |
| Capillary-Associated Microglia in Neurovascular Coupling: Localization, Mechanisms, and Disease Implications. | J Neuroinflammation | 2026 | 41668173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=3